Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL660384

COc1cc(C#N)ccc1NC(=O)CN.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHIT1 Q13231 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ HTT P42858 1/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ PDE4A P27815 2/20 0.43
▸ PDE4B Q07343 2/20 0.43
▸ PDE4C Q08493 2/20 0.43
▸ PDE4D Q08499 2/20 0.43
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ ADRA2C P18825 1/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40
▸ PDK3 Q15120 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL30440814 0.82 PYGL (0.47) CHIT1ALDH1A1HTTNPC1RAB9A
Trifluoroacetic Acid SCHEMBL17238937 0.82 PYGL (0.47) CHIT1ALDH1A1HTTNPC1RAB9A
SCHEMBL660385 0.76 MEN1 (0.40) PDE4APDE4BPDE4CPDE4DMEN1
Trifluoroacetic Acid SCHEMBL660305 0.76 HPGD (0.53) ALDH1A1NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL658391 0.74 ALDH1A1 (0.43) ALDH1A1HTTNPC1RAB9AMEN1
SCHEMBL28242416 0.74 CA12 (0.54) ALDH1A1HTTNPC1RAB9APDE4A
SCHEMBL17414148 0.74 LPAR1 (0.59) ALDH1A1HTTHPGDSMN1; SMN2MEN1
SCHEMBL658538 0.74 ALDH1A1 (0.42) ALDH1A1HTTNPC1RAB9AHPGD
SCHEMBL17238906 0.71 ALDH1A1 (0.54) ALDH1A1HTTNPC1RAB9APDE4A
Trifluoroacetic Acid SCHEMBL17238893 0.71 CA1 (0.49) ALDH1A1NPC1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012022707-A1 SUBSTITUTED HETEROARYL SPIROPYRROLIDINE MDM2 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2012-02-23 — — WO disclosed
US-20120046306-A1 Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists BARTKOVITZ DAVID JOSEPH (US) 2012-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046306-A1 Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists MDM2, TP53, RB1 CHIT1 4625/4885ALDH1A1 1065/4885HTT 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback